Download PDF
CC BY-NC-ND 4.0 · Laryngorhinootologie 2022; 101(S 01): S114-S143
DOI: 10.1055/a-1660-5591
Referat

Die Vagusnervstimulation bei konservativ therapierefraktärer Epilepsie und Depression

Article in several languages: deutsch | English
H Möbius
1   Klinik für HNO-Heilkunde, Kopf- und Halschirurgie, KRH Klinikum Nordstadt, Hannover
2   Abt. für HNO-Heilkunde, Kinderkrankenhaus auf der Bult, Hannover
,
H J Welkoborsky
1   Klinik für HNO-Heilkunde, Kopf- und Halschirurgie, KRH Klinikum Nordstadt, Hannover
2   Abt. für HNO-Heilkunde, Kinderkrankenhaus auf der Bult, Hannover
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Zusammenfassung

Zahlreiche Studien belegen, dass die Vagusnervstimulation (VNS) eine effiziente indirekte neuromodulatorische Therapie mit intermittierend appliziertem elektrischen Strom darstellt für die medikamentös therapierefraktäre Epilepsie, die nicht epilepsiechirurgisch interveniert werden kann, und die medikamentös therapierefraktäre Depression. Bei der VNS handelt es sich um eine etablierte, Evidenz basierte und in der Langzeitbetrachtung kosteneffektive Therapie in einem interdisziplinären Gesamtkonzept.

Es existieren Langzeitdaten zu Sicherheit und Verträglichkeit der Methode trotz großer Heterogenität der Patientenkollektive. Stimulationsbedingte Nebenwirkungen wie Heiserkeit, Parästhesien, Husten, Dyspnoe sind abhängig von der Stimulationsstärke und häufig mit fortschreitender Therapiedauer in den Folgejahren rückläufig. Stimulationsbezogene Nebenwirkungen der VNS sind durch Veränderung der Stimulationsparameter gut beeinflussbar. Insgesamt ist die invasive Vagusnervstimulation als sichere und gut verträgliche Therapieoption anzusehen.

Für die invasive und transkutane Vagusnervstimulation sind die antiepileptischen und antidepressiven sowie positive kognitive Effekte belegt. Im Gegensatz zu den Medikamenten wirkt sich die VNS nicht negativ auf die Kognition aus. Eine verbesserte Lebensqualität ist in vielen Fällen möglich.

Die iVNS-Therapie hat eine geringe Wahrscheinlichkeit der kompletten Anfallsfreiheit bei fokaler und genetisch generalisierter Epilepsie. Sie ist als palliative Therapie anzusehen, dass heisst, sie führt nicht zur Heilung und erfordert die Fortführung der spezifischen Medikation. Als Wirkprinzip wird eine allgemeine Reduktion neuronaler Exzitabilität betrachtet. Dieser Effekt stellt sich in einer langsamen Wirksamkeitssteigerung zum Teil über Jahre ein. Als Responder zählen Patienten mit einer mindestens 50%igen Reduktion der Anfallshäufigkeit. In Studien zeigt sich zum Teil in 20% der Fälle eine Anfallsfreiheit. Derzeit ist es nicht möglich, prätherapeutisch/präoperativ zwischen potentiellen Respondern und Non- Respondern zu differenzieren.

Durch die aktuellen technischen Weiterentwicklungen der VNS zur responsiven VNS Therapy mit Herzraten-basierter-Anfalls-Erkennung (CBSD) reduziert sich neben der Epilepsie-Anfallsschwere auch das SUDEP-Risiko (sudden unexpected death in epilepsy patients).

Die iVNS kann ein Schlaf-Apnoe-Syndrom verschlechtern und kann neben der engen Zusammenarbeit mit den Schlafmedizinern gegebenfalls eine nächtliche Therapiepause (z. B. Tag/Nacht-Programmierung) erfordern.

In Auswertung der zahlreichen iVNS-Studien der letzten 2 Jahrzehnte zeigten sich vielfältige positive Effekte auf weitere immunologische, kardiologische und gastroenterologische Erkrankungen, so dass sich je nach zukünftigen Studienergebnissen zusätzliche Therapieindikationen erwarten lassen. Aktuell ist die Vagusnervstimulation Gegenstand der Forschung in den Bereichen der Psychologie, Immunologie, Kardiologie, sowie Schmerz- oder Plastizitätsforschung mit erhofftem Potenzial zur zukünftigen medizinischen Anwendung.

Neben der invasiven Vagusnervstimulation wurden in den letzten Jahren Geräte zur transdermalen und somit nicht invasiven Vagusnervstimulation entwickelt. Diese haben nach den derzeit zur Verfügung stehenden Daten eine etwas geringere Wirksamkeit hinsichtlich der Verminderung von Anfallsschwere und Anfallsdauer bei der therapierefraktären Epilepsie und eine etwas geringe Wirksamkeit bei der Verbesserung von Symptomen der Depression. Hierzu fehlen in vielen Fällen noch Studien, die eine hohe Evidenz der Wirksamkeit nachweisen. Gleiches gilt für die beschriebenen sonstigen Indikationen wie z. B. Tinnitus, Cephalgien, Magen-Darm-Beschwerden etc. Ein weiterer Nachteil der transkutanen Vagusnervstimulation liegt darin, dass die Stimulatoren vom Patienten aktiv angesetzt werden müssen und somit nur intermittierend wirksam sind, was eine hohe Therapieadhärenz unsicher macht.

Schlüsselwörter

Epilepsie - Depression - Vagusnervstimulation - responsive Vagusnervstimulation - transkutane Vagusnervstimulation - Lebensqualität - Biomarker - Wirkmechanismus


Publication History

Article published online:
23 May 2022

© 2022. Thieme. All rights reserved. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Jacoby A, Snape D, Baker G. Epilepsy and social identity. The stigma of a chronic neurological disorder. The Lancet Neurology 2005; 4: 171-178
    CrossrefPubMedGoogle Scholar
  • 2 Pohlmann-Eden B, Beghi E, Camfield C, Camfield P. The first seizure and its management in adults and children. In BMJ (Clinical research ed.) 2006; 332: 339-342
    CrossrefPubMedGoogle Scholar
  • 3 Hauser WA. The prevalence and incidence of convulsive disorders in children. Epilepsia 1994; 35: 1-6
    CrossrefPubMedGoogle Scholar
  • 4 Fisher R, Cross JH, D’Souza C, French JA, Haut SR, Higurashi N. et al. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia 2017; 58: 531-542
    CrossrefPubMedGoogle Scholar
  • 5 Cordes N. Invasive vs. transkutane Vagusnervstimulation: Ein Vergleich beider Stimulationsarten hinsichtlich Effizienz sowie lebensqualitativer Aspekte bei therapierefraktärer Epilepsie- Untersuchungen durch das Epilepsiezentrum Marburg. Dissertation Marburg 2019 http://archiv.ub.uni-marburg.de/diss/z2019/0434/pdf/dnc.pdf
  • 6 Schneider F. et al. S3-Leitlinie/Nationale VersorgungsLeitlinie, Unipolare Depression, Kurzfassung, 2 Aufl. 2017, Version 1 AWMF-Register-Nr.: nvl-005
  • 7 Bijl RV, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998; 33: 587-595
    CrossrefPubMedGoogle Scholar
  • 8 Ebmeier KP, Donaghey C, Steele JD. Recent developments and current controversies in depression. Lancet 2006; 367: 153-167
    CrossrefPubMedGoogle Scholar
  • 9 Schneider F. et al. S3-Leitlinie/Nationale VersorgungsLeitlinie, Unipolare Depression, Kurzfassung, 2 Aufl. 2017, Version 1 AWMF-Register-Nr.: nvl-005
  • 10 Elger CE, Berkenfeld R. et al. S1-Leitlinie Erster epileptischer Anfall und Epilepsien im Erwachsenenalter. 2017. Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. Online: www.dgn.org/leitlinien (abgerufen am 24.08.2021) AWMF-Register-Nr.: 030-041
  • 11 Panebianco M, Zavanone C, Dupont S, Restivo DA, Pavone A. Vagus nerve stimulation therapy in partial epilepsy. A review. Acta neurologica Belgica 2016; 116: 241-248
    CrossrefPubMedGoogle Scholar
  • 12 Kwan P, Arzimanoglou A, Berg AT. et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51: 1069-1077
    CrossrefPubMedGoogle Scholar
  • 13 Yuen AWC, Sander JW. Can natural ways to stimulate the vagus nerve improve seizure control?. Epilepsy & behavior: E&B 2017; 67: 105-110
    CrossrefPubMedGoogle Scholar
  • 14 Zanchetti A, Wang SC, Moruzzi G. The effect of vagal afferent stimulation on the EEG pattern of the cat. Electroencephalography and clinical neurophysiology 1952; 4: 357-361
    CrossrefPubMedGoogle Scholar
  • 15 Chase MH, Nakamura Y, Clemente CD, Sterman MB. Afferent vagal stimulation: neurographic correlates of induced EEG synchronization and desynchronization. Brain Research. Elsevier; 1967. 5. 236-249
    Google Scholar
  • 16 Lockard JS, Congdon WC, DuCharme LL. Feasibility and Safety of Vagal Stimulation In Monkey Model. Epilepsia 1990; 31: 20-26
    CrossrefPubMedGoogle Scholar
  • 17 Woodbury DM, Woodbury JW. Effects of vagal stimulation on experimentally induced seizures in rats. Epilepsia 1990; 31: 7-19
    CrossrefPubMedGoogle Scholar
  • 18 McLachlan RS. Suppression of interictal spikes and seizures by stimulation of the vagus nerve. Epilepsia 1993; 34: 918-923
    CrossrefPubMedGoogle Scholar
  • 19 Fernandez-Guardiola A, Martinez A, Valdes-Cruz A. Vagus nerve prolonged stimulation in cats: effects on epileptogenesis (amygdala electrical kindling): behavioral and electrographic changes. Epilepsia 1999; 40: 822-829
    CrossrefPubMedGoogle Scholar
  • 20 Zabara J. Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia. 1992; 33: 1005-1012
    CrossrefPubMedGoogle Scholar
  • 21 Penry JK, Dean IC. Prevention of intractable partial seizures by intermittent vagal stimulation in humans: Preliminary results [abstract]. Epilepsy 1990; 31: 40-43
    CrossrefPubMedGoogle Scholar
  • 22 Rutecki P. Anatomical, physiological and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia. 1990; 31: 1-6
    CrossrefPubMedGoogle Scholar
  • 23 Uthman BM, Wilder BJ, Penry JK, Dean C, Ramsay RE, Reid S. et al. Treatment of epilepsy by stimulation of the vagus nerve. Neurology 1993; 43: 1338-1345
    CrossrefPubMedGoogle Scholar
  • 24 Morris GL, Mueller WM. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01–E05. Neurology 1999; 53: 1731-1735
    CrossrefPubMedGoogle Scholar
  • 25 Elger G. et al. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 2000; 42: 203-210
    CrossrefPubMedGoogle Scholar
  • 26 Sackeim HA. et al. Vagus Nerve Stimulation (VNS™) for Treatment-Resistant Depression: Efficacy, Side Effects, and Predictors of Outcome. Neuropsychopharmacology 2001; 25: 713-728
    CrossrefPubMedGoogle Scholar
  • 27 Rush AJ. et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005; 58: 347-354
    CrossrefPubMedGoogle Scholar
  • 28 Bajboui M, Merkl A. et al. Two-Year Outcome of Vagus Nerve Stimulation inTreatment-Resistant Depression. Journal of Clinical Psychopharmacology 2010; 30: 273-281
    CrossrefPubMedGoogle Scholar
  • 29 Aaronson ST, Sears P, Ruvuna F. et al. A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality. American Journal of Psychiatry 2017; 174: 640-648
    CrossrefPubMedGoogle Scholar
  • 30 Feldman RL, Dunner DL, Muller JS, Stone DA. Medicare patient experience with vagus nerve stimulation for treatment-resistant depression. J Med Econ 2013; 16: 62-74
    CrossrefPubMedGoogle Scholar
  • 31 Panebianco M, Zavanone C, Dupont S, Restivo DA, Pavone A. Vagus nerve stimulation therapy in partial epilepsy. A review. In: Acta neurologica Belgica 2016; 116: 241-248
    CrossrefPubMedGoogle Scholar
  • 32 Yuen AWC, Sander JW. Can natural ways to stimulate the vagus nerve improve seizure control?. In: Epilepsy & behavior: E&B 2017; 67: 105-110
    CrossrefPubMedGoogle Scholar
  • 33 Premchand RK, Sharma K, Mittal S, Monteiro R, Dixit S, Libbus I. et al. Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure. Results of the ANTHEM-HF trial. Journal of cardiac failure 2014; 20: 808-816
    CrossrefPubMedGoogle Scholar
  • 34 Amar AP. Vagus nerve stimulation for the treatment of intractable epilepsy. In: Expert review of neurotherapeutics 2007; 7: 1763-1773
    CrossrefPubMedGoogle Scholar
  • 35 PLC LivaNova, London, UK VNS Therapy System Epilepsy, Physician’s Manual (OUS), August 2020
  • 36 Howland RH. New developments with vagus nerve stimulation therapy. Journal of psychosocial nursing and mental health services 2014; 52: 11-14
    PubMedGoogle Scholar
  • 37 Bertolini R, Leutert G. Systematische Anatomie des Menschen. Verlag Volk und Gesundheit 1987; 3: 431-435
    PubMedGoogle Scholar
  • 38 Hirsch M, Reinacher P, Schulze-Bonhage A. Vagusnervstimulation in der Behandlung von Epilepsiepatienten. Aktuelle Neurologie 2016; 43: 501-510 DOI: 10.1055/s-0042-116022.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex – linking immunity and metabolism. Nat. Rev. Endocrinol 2012; 8: 743-754 DOI: 10.1038/nrendo.2012.189.
    CrossrefPubMedGoogle Scholar
  • 40 Camara R, Griessenauer CJ. Anatomy of the Vagus Nerve. Nerves and Nerve Injuries 2015; 1: 385-397
    PubMedGoogle Scholar
  • 41 Thompson N, Mastitskaya S, Holder D. Avoiding off-target effects in electrical stimulation of the cervical vagus nerve: neuroanatomical tracing techniques to study fascicular anatomy of the vagus nerve. Journal of Neuroscience Methods 2019; 325: 108325 DOI: 10.1016/j.jneumeth.2019.108325.
    CrossrefPubMedGoogle Scholar
  • 42 Bonaz B, Sinniger V, Pellissier S. Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. J Physiol 2016; 594: 5781-5790 DOI: 10.1113/JP271539..
    CrossrefPubMedGoogle Scholar
  • 43 Standring S et al. Gray´s Anatomy. The Anatomical Basis of Clinical Practice. 42. Ed. Elsevier Limited, 2021
  • 44 Oliveira THF, Francisco AN, Demartini Z, Stebel SL. The role of vagus nerve stimulation in refractory epilepsy. Arquivos de neuro-psiquiatria 2017; 75: 657-666
    CrossrefPubMedGoogle Scholar
  • 45 Ekmekci H, Kaptan H. Vagus Nerve Stimulation. Open access Macedonian journal of medical sciences 2017; 5: 391-394
    CrossrefPubMedGoogle Scholar
  • 46 Camara R, Griessenauer CJ. Chapter 27 - Anatomy of the Vagus Nerve. Nerves and Nerve Injuries. Elsevier Ltd; 2015. Vol. 1. 385-397 DOI: 10.1016/B978-0-12-410390-0.00028-7
    Google Scholar
  • 47 Shiozawa P. Vagus nerve stimulation in neuropsychiatry. Targeting anatomy-based stimulation sites. Epilepsy & behavior: E&B 2015; 51: 18
    CrossrefPubMedGoogle Scholar
  • 48 Verlinden TJM, Rijkers K, Hoogland G, Herrler A. Morphology of the human cervical vagus nerve: implications for vagus nerve stimulation treatment. Acta Neurol. Scand 2016; 133: 173-182 DOI: 10.1111/ane.12462).
    CrossrefPubMedGoogle Scholar
  • 49 Beckett EAH, Sanders KM, Ward SM. Inhibitory responses mediated by vagal nerve stimulation are diminished in stomachs of mice with reduced intramuscular interstitial cells of Cajal. Sci Rep 2017; 7: 44759 DOI: 10.1038/srep44759.
    CrossrefPubMedGoogle Scholar
  • 50 Shiozawa P. Vagus nerve stimulation in neuropsychiatry. Targeting anatomy-based stimulation sites. Epilepsy & behavior : E&B 2015; 51: 18
    CrossrefPubMedGoogle Scholar
  • 51 Gasser HS, Grundfest H. Axon diameters in relation to the spike dimensions and the conduction velocity in mammalian A fibers. Am J Physiol 1939; 127: 393-414
    CrossrefPubMedGoogle Scholar
  • 52 Krahl SE, Senanayake SS, Handforth A. Destruction of peripheral C-fibers does not alter subsequent vagus nerve stimulation-induced seizure suppression in rats. Epilepsia 2001; 42: 586-589
    CrossrefPubMedGoogle Scholar
  • 53 Penry JK, Dean IC. Prevention of intractable partial seizures by intermittent vagal stimulation in humans: Preliminary results [abstract]. Epilepsy 1990; 31: 40-43
    CrossrefPubMedGoogle Scholar
  • 54 Bailey P, Bremer F. A sensory cortical representation of the vagus nerve (with a note on the effects of low blood pressure on the cortical electrograms). J Neurophysiol 1938; 1: 405-412
    CrossrefPubMedGoogle Scholar
  • 55 MacLean PD. The Triune Brain in Evolution: Role in Paleocerebral Functions. New York: Plenum Press; 1990. DOI: 10.1126/science.250.4978.303-a
    CrossrefGoogle Scholar
  • 56 Dell P, Olson R. Projections ‘secondaires’ mesencephaliques, diencephaliques et amygdaliennes des afferences viscerales vagales. C R Soc Biol 1951; 145: 1088-1091
    PubMedGoogle Scholar
  • 57 Zabara J. Peripheral control of hypersynchronous discharge in epilepsy. Electroencephalogr Neu-rophysiol 1985; 61: 162
    CrossrefPubMedGoogle Scholar
  • 58 Hermanowicz N. Chapter 13 – cranial nerves IX (glossopharyngeal) and X (vagus). Textbook of clinical neurology 2007; 217-229 DOI: 10.1016/B978-141603618-0.10013-X.
    CrossrefPubMedGoogle Scholar
  • 59 Monkhouse S. 15 - The vagus nerve (X). Cambridge University Press; 2006: 86-91 DOI: 10.1017/CBO9780511543524.016
    CrossrefGoogle Scholar
  • 60 Camara R, Griessenauer CJ. Anatomy of the Vagus Nerve. Nerves and Nerve Injuries 2015; 1 DOI: 10.1016/B978-0-12-410390-0.00028-7.
    CrossrefPubMedGoogle Scholar
  • 61 Gilman S, Chervin RD, Koeppe RA, Consens FB, Little R, Junck L. Heumann. Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA. Neurology 2003; 61: 35-39 Neurology 2003; 61: 35–39
    CrossrefPubMedGoogle Scholar
  • 62 Hachem LD, Wong SM, Ibrahim GM. The vagus afferent network: emerging role in translational connectomics. Neurosurg Focus 2018; 45: 1-8 DOI: 10.3171/2018.6.FOCUS18216.
    CrossrefPubMedGoogle Scholar
  • 63 George MS, Sackeim HA. et al. Vagus nerve stimulation: A new tool for brain research and therapy. Biol Psychiatry 2000; 47: 287-295
    CrossrefPubMedGoogle Scholar
  • 64 George MS, Sackeim HA. et al. Vagus nerve stimulation. A potential therapy for resistant depression?. Psych Clin North Am 2000; 23: 757-783
    CrossrefPubMedGoogle Scholar
  • 65 Rush AJ, Linden M, Zobel A. Vagus Nerve Stimulation. A Potential Therapy for Chronic/Recurrent Depression?. Fortschritte der Neurologie • Psychiatrie 2002; 70: 297-302 DOI: 10.1055/s-2002-32022.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 66 Van Bockstaele EJ, Peoples J. et al. Anatomic basis for differential regulation of the rostrolateral pen-locus coeruleus region by limbic afferents. Biol Psychiatry 1999; 46: 1352-1363
    CrossrefPubMedGoogle Scholar
  • 67 Ricardo JA, Koh ET. Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures. Brain Res 1978; 152: 1-10
    CrossrefPubMedGoogle Scholar
  • 68 Otterson OP. Afferent connection to the amygdaloin complex of the rat with some observations in the cat. III. Afferents from lower brainstem. J Comp Neurol 1981; 202: 335
    CrossrefPubMedGoogle Scholar
  • 69 Zardetto-Smith AM, Gray TS. Organization of peptidergic and catecholaminergic efferents from the nucleus of the solitary tract to the rat amygdala. Brain Res Bull 1990; 25: 875
    CrossrefPubMedGoogle Scholar
  • 70 Van der Kooy D, Koda LY, McGinty JF, Gerfen CR, Bloom FE. The organization of projections from the cortex, amygdala, and hypothalamus to the nucleus of the solitary tract in the rat. J Comp Neurol 1984; 224: 1-20
    CrossrefPubMedGoogle Scholar
  • 71 Krahl SE, Clark KB, Smith DC, Browning RA. Locus coeruleus lesions suppress the seizure attenuating effects of vagus nerve stimulation. Epilepsia 1998; 39: 709-714
    CrossrefPubMedGoogle Scholar
  • 72 Henry TR. Therapeutic mechanisms of vagus nerve stimulation. In: Neurology 2002; 59: 3-14
    CrossrefPubMedGoogle Scholar
  • 73 Ng GA, Brack KE, Coote JH. Effects of direct sympathetic and vagus nerve stimulation on the physiology of the whole heart – a novel model of isolated langendorff perfused rabbit heart with intact dual autonomic innervation. Exp. Physiol 2001; 86: 319-329 DOI: 10.1113/eph8602146.
    CrossrefPubMedGoogle Scholar
  • 74 Yoo PB, Liu H, Hincapie JG, Ruble SB, Hamann JJ, Grill WM. Modulation of heart rate by temporally patterned vagus nerve stimulation in the anesthetized dog. Physiol. Rep 2016; 4: 12689 DOI: 10.14814/phy2.12689.
    CrossrefPubMedGoogle Scholar
  • 75 Tekdemir I, Aslan A, Elhan A. A clinico-anatomic study of the auricular branch of the vagus nerve and Arnold’s ear-cough reflex. Surg Radiol Anat 1998; 20: 253-257
    PubMedGoogle Scholar
  • 76 Leblanc A. Anatomy and Imaging of the Cranial Nerves, A Neuroanatomic Method of Investigation Using Magnetic Resonance Imaging (MRI) and Computed Tomography (CT). Springer Berlin Heidelberg, Berlin, Heidelberg 1992; DOI: 10.1007/978-3-642-97042-9.
    CrossrefPubMedGoogle Scholar
  • 77 Reidler PL. Einfluss der transkutanen Vagusnervstimulation auf die funktionelle Konnektivität bei chronischen Schmerzpatienten: Eine fMRT-basierte Pilotstudie. Dissertation München 2019; https://edoc.ub.unimuenchen.de/24617/1/Reidler_Paul.pdf
  • 78 Nomura S, Mizuno N. Central distribution of primary afferent fibers in the Arnold’s nerve (the auricular branch of the vagus nerve): A transganglionic HRP study in the cat. Brain Res 1984; 292: 199-205 DOI: 10.1016/0006-8993(84)90756-X.
    CrossrefPubMedGoogle Scholar
  • 79 Walker BR, Easton A, Gale K. Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius. Epilepsia 1999; 40: 1051-1057
    CrossrefPubMedGoogle Scholar
  • 80 Raedt R, Clinckers R, Mollet L. et al. Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model. J Neurochem 2011; 117: 461-469
    CrossrefPubMedGoogle Scholar
  • 81 Nahas Z, Teneback C, Chae JH, Mu Q, Molnar C, Kozel FA, Walker J, Anderson B, Koola J, Kose S, Lomarev M, Bohning DE, George MS. Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacol 2007; 32: 1649-1660 DOI: 10.1038/sj.npp.1301288.
    CrossrefPubMedGoogle Scholar
  • 82 Zhu J, Xu C, Zhang X, Qiao L, Wang X, Zhang X, Yan X, Ni D, Yu T, Zhang G, Li Y. A resting-state functional MRI study on the effect of vagal nerve stimulation on spontaneous regional brain activity in drug-resistant epilepsy patients. Behav Brain Res 2020; 392: 112709 DOI: 10.1016/j.bbr.2020.112709.
    CrossrefPubMedGoogle Scholar
  • 83 Nemeroff CB, Mayberg HS, Krahl SE, McNamara J, Frazer A, Henry TR, George MS, Charney DS, Brannan SK. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacol 2006; 31: 1345-1355 DOI: 10.1038/sj.npp.1301082.
    CrossrefPubMedGoogle Scholar
  • 84 Mu Q, Bohning DE, Nahas Z, Walker J, Anderson B, Johnson KA, Denslow S, Lomarev M, Moghadam P, Chae JH, George MS. Acute vagus nerve stimulation using different pulse widths produces varying brain effects. Biol Psychiatry 2004; 55: 816-825 DOI: 10.1016/j.biopsych.2003.12.004.
    CrossrefPubMedGoogle Scholar
  • 85 Lomarev M, Denslow S, Nahas Z, Chae JH, George MS, Bohning DE. () Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. J Psychiatr Res 2002; 36: 219-227 DOI: 10.1016/s0022-3956(02)00013-4.
    CrossrefPubMedGoogle Scholar
  • 86 Smith LJ, Rosen CA, Niyonkuru C, Munin MC. Quantitative electromyography improves prediction in vocal fold paralysis. The Laryngoscope 2012; 122: 854-859
    CrossrefPubMedGoogle Scholar
  • 87 Koopman FA, Tang MW, Vermeij J, de Hair MJ, Choi IY, Vervoordeldonk MJ. et al. Autonomic dysfunction precedes development of rheumatoid arthritis: a prospective cohort study. EBioMedicine 2016; 6: 231-237 DOI: 10.1016/j.ebiom.2016.02.029.
    CrossrefPubMedGoogle Scholar
  • 88 Bonaz B, Sinniger V, Pellissier S. Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. J Physiol 2016; 594: 5781-5790 DOI: 10.1113/JP271539.
    CrossrefPubMedGoogle Scholar
  • 89 Bonaz B, Sinniger V, Pellissier S. Vagus nerve stimulation: a new promising therapeutic tool in inflammatory bowel disease. J Intern Med 2017; 282: 46-63 DOI: 10.1111/joim.12611.
    CrossrefPubMedGoogle Scholar
  • 90 Fisher RS, Eggleston KS, Wright CW. Vagus nerve stimulation magnet activation for seizures: A critical review. Acta Neurol Scand 2014; 131(1) DOI: 10.1111/ane.12288.
    CrossrefPubMedGoogle Scholar
  • 91 Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol 2002; 1: 477-482
    CrossrefPubMedGoogle Scholar
  • 92 Handforth A, DeGiorgio CM, Schachter SC. et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998; 51: 48-55
    CrossrefPubMedGoogle Scholar
  • 93 Kahlow H, Olivecrona M. Complications of vagal nerve stimulation for drug-resistant epilepsy: a single center longitudinal study of 143 patients. Seizure 2013; 22: 827-833
    CrossrefPubMedGoogle Scholar
  • 94 Tatum WO, Moore DB, Stecker MM. et al. Ventricular asystole during vagus nerve stimulation for epilepsy in humans. Neurology 1999; 52: 1267-1269
    CrossrefPubMedGoogle Scholar
  • 95 Ardesch JJ, Buschman HPJ, van der Burgh PH. et al. Cardiac responses of vagus nerve stimulation: intraoperative bradycardia and subsequent chronic stimulation. Clin Neurol Neurosurg 2007; 109: 849-852
    CrossrefPubMedGoogle Scholar
  • 96 Ben-Menachem E. Vagus nerve stimulation, side effects, and long-term safety. Journal of clinical neurophysiology: official publication of the American Electroencephalographic Society 2001; 18: 415-418
    CrossrefPubMedGoogle Scholar
  • 97 Gandhi H, Ippoliti M, Iqbal F, Shah A. Bradyarrhythmia secondary to vagus nerve stimulator 7 years after placement. BMJ Case Rep 2020; 13: e235514 DOI: 10.1136/bcr-2020-235514.
    CrossrefPubMedGoogle Scholar
  • 98 Spuck S, Tronnier V, Orosz I, Schönweiler R. et al. Operative and technical complications of vagus nerve stimulator implantation. Neurosurgery. 2010; 67: 489-494 DOI: 10.1227/NEU.0b013e3181f88867.
    CrossrefPubMedGoogle Scholar
  • 99 Revesz D, Rydenhag B, Ben-Menachem E. Complications and safety of vagus nerve stimulation: 25 years of experience at a single center. J Neurosurg Pediatr 2016; DOI: 10.3171/2016.1.PEDS15534.
    CrossrefPubMedGoogle Scholar
  • 100 Morris GL, Mueller WM. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01–E05. Neurology 1999; 53: 1731-1735
    CrossrefPubMedGoogle Scholar
  • 101 Morris GL, Gloss D, Buchhalter J. et al. Evidence-based guideline update: Vagus nerve stimulation for the treatment of epilepsy: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2013; DOI: 10.1212/WNL.0b013e3182a393d1.
    CrossrefPubMedGoogle Scholar
  • 102 Elliott RE, Morsi A, Kalhorn SP, Marcus J. et al. Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: Long-term outcomes and predictors of response. Epilepsy & Behavior 2011; 20: 57-63
    CrossrefPubMedGoogle Scholar
  • 103 Englot DJ, Hassnain KH, Rolston JD, Harward SC, Sinha SR, Haglund MM. Quality-of-life metrics with vagus nerve stimulation for epilepsy from provider survey data. Epilepsy & Behavior 2017; 66: 4-9
    CrossrefPubMedGoogle Scholar
  • 104 Orosz I, McCormick D, Zamponi N, Varadkar S. et al. Vagus nerve stimulation for drug-resistant epilepsy: A European long-term study up to 24 months in 347 children. Epilepsia 2014; 55: 1576-1584
    CrossrefPubMedGoogle Scholar
  • 105 Ben-Menachem E. Vagus nerve stimulation, side effects, and long-term safety. J Clin Neurophysiol 2001; 18: 415-418
    CrossrefPubMedGoogle Scholar
  • 106 Parhizgar F, Nugent K, Raj R. Obstructive sleep apnea and respiratory complications associated with vagus nerve stimulators. J Clin Sleep Med 2011; 7: 401-407
    CrossrefPubMedGoogle Scholar
  • 107 Hsieh T, Chen M, McAfee A. et al. Sleep-related breathing disorder in children with vagal nerve stimulators. Pediatr Neurol 2008; 38: 99-103
    CrossrefPubMedGoogle Scholar
  • 108 Grigg-Damberger M, Foldvary-Schaefer N. Bidirectional relationships of sleep and epilepsy in adults with epilepsy. Epilepsy & Behavior 2021; 116: 107735 DOI: 10.1016/j.yebeh.2020.107735.
    CrossrefPubMedGoogle Scholar
  • 109 Malow BA, Edwards J, Marzec M. et al. Effects of vagus nerve stimulation on respiration during sleep: a pilot study. Neurology 2000; 55: 1450-1454
    CrossrefPubMedGoogle Scholar
  • 110 Marzec M, Edwards J, Sagher O. et al. Effects of vagus nerve stimulation on sleep-related breath-ing in epilepsy patients. Epilepsia 2003; 44: 930-935
    CrossrefPubMedGoogle Scholar
  • 111 Gschliesser V, Högl B, Frauscher B. et al. Mode of vagus nerve stimulation differentially affects sleep related breathing in patients with epilepsy. Seizure 2009; 18: 339-342
    CrossrefPubMedGoogle Scholar
  • 112 Beekwilder JP, Beems T. Overview of the clinical applications of vagus nerve stimulation. J Clin Neurophysiol 2010; 27: 130-138
    CrossrefPubMedGoogle Scholar
  • 113 Helmers SL. et al. Acta Neurol. Scand 2012; Heck C et al. Neurology 2002; 59: 31-37
    CrossrefPubMedGoogle Scholar
  • 114 Thompson SL, O´Leary G, Austelle CW. et al. A Review of Parameter Settings for Invasive and Non-invasive Vagus Nerve Stimulation (VNS) Applied in Neurological and Psychiatric Disorders. Front. Neurosci 2021; 15: 1-14 DOI: 10.3389/fnins.2021.709436.
    CrossrefPubMedGoogle Scholar
  • 115 Smith CD, Geddes LA, Bourland JD, Foster KS, Schoenlein WE. The chronaxie and propagation velocity of canine cervical vagus nerve fibers in vivo. Cardiovasc Eng 2001; 1: 77-84
    CrossrefPubMedGoogle Scholar
  • 116 Helmers SL, Begnaud J, Cowley AW, Corwin HM, Edwards JC, Holder DL. et al. Application of a computational model of vagus nerve stimulation. Acta Neurol Scand 2012; 126: 336-343
    CrossrefPubMedGoogle Scholar
  • 117 Castoro MA, Yoo PB, Hincapie JG. et al. Excitation properties of the right cervical vagus nerve in adult dogs. Exp Neurol 2011; 227: 62-8.19
    CrossrefPubMedGoogle Scholar
  • 118 El Tahry R, Mollet L, Raedt R. et al. Repeated assessment of larynx compound muscle action potentials using a self-sizing cuff electrode around the vagus nerve in experimental rats. J Neurosci Methods 2011; 198: 287-293
    CrossrefPubMedGoogle Scholar
  • 119 Koo B, Ham SD, Sood S. et al. Human vagus nerve electrophysiology: a guide to vagus nerve stimulation parameters. J Clin Neurophysiol 2001; 18: 429-433
    CrossrefPubMedGoogle Scholar
  • 120 Evans MS, Verma-Ahuja S, Naritoku DK. et al. Intraoperative human vagus nerve compound action potentials. Acta Neurol Scand 2004; 110: 232-238
    CrossrefPubMedGoogle Scholar
  • 121 Woodbury JW, Woodbury DM. Vagal stimulationreduces the severity of maximal electroshock seizures in intact rats: use of a cuff electrode for stimulating and recording. Pace 1991; 14: 94-107 1991
    CrossrefPubMedGoogle Scholar
  • 122 Krahl SE, Senanayake SS, Handforth A. Destruction of peripheral c-fibers does not alter subse-quent vagus nerve stimulation-induced seizure suppression in rats. Epilepsia 2001; 42: 586-589
    CrossrefPubMedGoogle Scholar
  • 123 Koo B, Ham SD, Sood S, Tarver B. Human Vagus Nerve Electrophysiology A Guide to Vagus Nerve Stimulation Parameters. Journal of Clinical Neurophysiology 2001; 18: 429-433
    CrossrefPubMedGoogle Scholar
  • 124 Helmers SL, Begnaud J, Cowley AW, Corwin HM, Edwards JC, Holder DL. et al. Application of a computational model of vagus nerve stimulation. Acta Neurol Scand 2012; 126: 336-343
    CrossrefPubMedGoogle Scholar
  • 125 Fisher B, DesMarteau J, Koontz E, Wilks S, Melamed S. Responsive Vagus Nerve Stimulation for Drug Resistant Epilepsy: A Review of New Features and Practical Guidance for Advanced Practice Providers. Frontiers in Neurology 2021; 11: 1-10 DOI: 10.3389/fneur.2020.610379.
    CrossrefPubMedGoogle Scholar
  • 126 Gurbani SG, Mittal M, Gurbani N. et al. Efficacy of rapid cycling vagus nerve stimulation in pharmaco-resistant epilepsy. Neurology Asia 2004; 9: 131
    PubMedGoogle Scholar
  • 127 Kayyali H. et al. The Efficacy and Safety of Rapid Cycling Vagus Nerve Stimulation in Children with Intractable Epilepsy. Pediatric Neurology 2020; 109: 35-38
    CrossrefPubMedGoogle Scholar
  • 128 O´Reardon JP. et al. A case study of refractory major depression with a delayed response to vagus nerve stimulation (vns): optimizing the duty cycle to improve efficacy. Depression: Mind and Body 2006; 3: 32-34
    PubMedGoogle Scholar
  • 129 Larsen LE, Wadman WJ, Marinazzo D, van Mierlo P. et al. Vagus Nerve Stimulation applied with a rapid cycle has more profound influence on hippocampal electrophysiology than a standard cycle. Neurotherapeutics 2016; 13: 592-602 DOI: 10.1007/s13311-016-0432-8.
    CrossrefPubMedGoogle Scholar
  • 130 Gurbani SG, Mittal M, Gurbani N. et al. Efficacy of rapid cycling vagus nerve stimulation in pharmaco-resistant epilepsy. Neurology Asia 2004; 9: 131
    PubMedGoogle Scholar
  • 131 Panebianco M, Zavanone C, Dupont S, Restivo DA, Pavone A. Vagus nerve stimulation therapy in partial epilepsy. A review. Acta neurologica Belgica 2016; 116: 241-248
    CrossrefPubMedGoogle Scholar
  • 132 Mu Q, Bohning DE, Nahas Z, Walker J, Anderson B. et al. Acute Vagus Nerve Stimulation Using Different Pulse Widths Produces Varying Brain Effects. BIOL PSYCHIATRY 2004; 55: 816-825 DOI: 10.1016/j.biopsych.2003.12.004.
    CrossrefPubMedGoogle Scholar
  • 133 Boon P, Vonck K, van Walleghem P. et al. Programmed and magnet-induced vagus nerve stimulation for refractory epilepsy. J Clin Neurophysiol 2001; 18: 402-407
    CrossrefPubMedGoogle Scholar
  • 134 Morris GL. A retrospective analysis of the effects of magnet-activated stimulation in conjunction with vagus nerve stimulation therapy. Epilepsy Behav 2003; 4: 740-745
    CrossrefPubMedGoogle Scholar
  • 135 Chouchou F, Bouet R, Pichot V. et al. The neural bases of ictal tachycardia in temporal lobe seizures. Clin Neurophysiol 2017; 128: 1810-1819 DOI: 10.1016/j.clinph.2017.06.033 .
    CrossrefPubMedGoogle Scholar
  • 136 Eggleston KS, Olin DO, Fisher RS. Ictal tachycardia: the head-heart connection. Seizure 2014; 23: 496-505
    CrossrefPubMedGoogle Scholar
  • 137 Hirsch M, Altenmüller DM, Schulze-Bonhage A. Latencies from intracranial seizure onset to ictal tachycardia: A comparison to surface EEG patterns and other clinical signs. Epilepsia 2015; 56: 1639-1647
    CrossrefPubMedGoogle Scholar
  • 138 Leutmezer F, Schernthaner C, Lurger S, Pötzelberger K, Baumgartner C. Electrocardiographic changes at the onset of epileptic seizures. Epilepsia 2003; 44: 348-354
    CrossrefPubMedGoogle Scholar
  • 139 Boon P, Vonck K, van Rijckevorsel K. et al. A prospective, multicenter study of cardiac-based seizure detection to activate vagus nerve stimulation. Seizure 2015; 32: 52-61
    CrossrefPubMedGoogle Scholar
  • 140 El Tahry R, Hirsch M, Van Rijckevorsel K. et al. Early experiences with tachycardia-triggered vagus nerve stimulation using the AspireSR stimulator. Epileptic Disord 2016; 18: 155-162
    CrossrefPubMedGoogle Scholar
  • 141 Bialer M. et al. Seizure detection and neuromodulation: A summary of data presented at the XIII conference on new antiepileptic drug and devices (EILAT XIII). Epilepsy Research 2017; 130: 27-36
    CrossrefPubMedGoogle Scholar
  • 142 Hampel KG, Vatter H, Elger CE. et al. Cardiac-based vagus nerve stimulation reduced seizure duration in a patient with refractory epilepsy. Seizure 2015; 26: 81-85
    CrossrefPubMedGoogle Scholar
  • 143 Ravan M, Sabesan S. et al. On Quantitative Biomarkers of VNS Therapy Using EEG and ECG Signals. Transactions on Biomedical Engineerig 2017; 64: 419-428
    CrossrefPubMedGoogle Scholar
  • 144 Page T, Fergus J, Rugg-Gunn FJ. Bitemporal seizure spread and its effect on autonomic dysfunction. Epilepsy & Behavior 2018; 84: 166-172
    CrossrefPubMedGoogle Scholar
  • 145 Ryvlin P, So EL, Gordon CM, Hesdorffer DC. et al. Long-term surveillance of SUDEP in drug-resistant epilepsy patients treated with VNS therapy. Epilepsia 2018; 59: 562-572
    CrossrefPubMedGoogle Scholar
  • 146 Ventureyra EC. Transcutaneous vagus nerve stimulation for partial onset seizure therapy. A new concept. In: Child’s nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2000; 16: 101-102
    CrossrefPubMedGoogle Scholar
  • 147 Stefan H, Kreiselmeyer G, Kerling F, Kurzbuch K. et al. Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: A proof of concept trial. Epilepsia 2012; 53: 115-118
    CrossrefPubMedGoogle Scholar
  • 148 Peuker ET, Filler TJ. The nerve supply of the human auricle. Clin. Anat. 2002; 15: 35-37 DOI: 10.1002/ca.1089.
    CrossrefPubMedGoogle Scholar
  • 149 Hecker H, Steveling A, Peuker E. Lehrbuch und Repititorium Ohr-, Schädel-, Mund- Hand-Akupunktur. 3. Aufl. 2002. Hippokrates Verlag Stuttgart. S.7
  • 150 Yuan H, Silberstein SD. Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review. Part II. Headache 2016; 56: 259-266
    CrossrefPubMedGoogle Scholar
  • 151 Bauer S, Baier H, Baumgartner C. et al. Transcutaneous Vagus Nerve Stimulation (tVNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial (cMPsE02). Brain Stimulation 2016; 9: 356-363
    CrossrefPubMedGoogle Scholar
  • 152 Rong PJ, Liu AH. et al. Transcutaneous vagus nerve stimulation for refractory epilepsy: a random-ized controlled trial. Portland Press 2014 Clin Sci (Lond) 2014; CS20130518. 10.1042/CS20130518
  • 153 Fallgatter AJ, Neuhauser B, Herrmann MJ. et al. Far field potentials from the brain stem after transcutaneous vagus nerve stimulation. J Neural Transm 2003; 110: 1437-1443
    CrossrefPubMedGoogle Scholar
  • 154 Kraus T, Hosl K, Kiess O, Schanze A, Kornhuber J, Forster C. BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation. J Neural Transm 2007; 114: 1485-1493
    CrossrefPubMedGoogle Scholar
  • 155 Dietrich S, Smith J, Scherzinger C. et al. A novel transcutaneous vagus nerve stimulation leads to brainstem and cerebral activations measured by functional MRI. Biomed Tech (Berl) 2008; 53: 104-111
    CrossrefPubMedGoogle Scholar
  • 156 Howland RobertH. New developments with vagus nerve stimulation therapy. Journal of psychosocial nursing and mental health services 52: 11-14
    PubMedGoogle Scholar
  • 157 Farmer AD, Strzelczyk A, Finiguerra A. et al. International Consensus Based Review and Recom-mendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020). Front Hum Neurosci 2021; 14: 1-47 DOI: 10.3389/fnhum.2020.568051.
    CrossrefPubMedGoogle Scholar
  • 158 Clancy JA, Deuchars SA, Deuchars J. The wonders of the Wanderer. Exp. Physiol 2013; 98: 38-45 DOI: 10.1113/expphysiol.2012.064543.
    CrossrefPubMedGoogle Scholar
  • 159 Chakravarthy K, Chaudhry H, Williams K, Christo PJ. Review of the Uses of Vagal Nerve Stimulation in Chronic Pain Management. Curr. Pain Headache Rep 2015; 19: 54 DOI: 10.1007/s11916-015-0528-6.
    CrossrefPubMedGoogle Scholar
  • 160 Yuan H, Silberstein SD. Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part II. Headache 2016; 56: 259-266 DOI: 10.1111/head.12650.
    CrossrefPubMedGoogle Scholar
  • 161 Kreuzer PM, Landgrebe M. et al. Transcutaneous vagus nerve stimulation: retrospective assessment of cardiac safety in a pilot study. Front Psychiatry 2012; 3: 70 DOI: 10.3389/fpsyt.2012.00070.
    CrossrefPubMedGoogle Scholar
  • 162 Stefan H, Kreiselmeyer G, Kerling F, Kurzbuch K, Rauch C, Heers M. et al. Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies. A proof of concept trial. Epilepsia 2012; 53: 115-118
    CrossrefPubMedGoogle Scholar
  • 163 Bauer S, Baier H, Baumgartner C, Bohlmann K, Fauser S, Graf W. et al. Transcutaneous Vagus Nerve Stimulation (tVNS) for Treatment of Drug- Resistant Epilepsy. A Randomized, Double-Blind Clinical Trial (cMPsE02). Brain stimulation 2016; 9: 356-363
    CrossrefPubMedGoogle Scholar
  • 164 Schulze-Bonhage A. Brain stimulation as a neuromodulatory epilepsy therapy. Seizure 2017; 44: 169-175
    CrossrefPubMedGoogle Scholar
  • 165 Mertens A, Raedt R, Gadeyne S, Carrette E, Boon P, Vonck K. Recent advances in devices for vagus nerve stimulation. Expert Rev Med Devices 2018; 15: 527-539
    CrossrefPubMedGoogle Scholar
  • 166 De Couck M, Cserjesi R, Caers R, Zijlstra WP, Widjaja D, Wolf N. et al. Effects of short and pro-longed transcutaneous vagus nerve stimulation on heart rate variability in healthy subjects. Auton Neurosci 2017; 203: 88-96
    CrossrefPubMedGoogle Scholar
  • 167 Premchand RK, Sharma K, Mittal S, Monteiro R, Dixit S, Libbus I. et al. Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial. J. Cardiac Failure 2014; 20: 808-816
    CrossrefPubMedGoogle Scholar
  • 168 Wang Z, Zhou X, Sheng X, Yu L, Jiang H. Noninvasive vagal nerve stimulation for heart failure: was it practical or just a stunt. Int J Cardiol 2015; 187: 637-638
    CrossrefPubMedGoogle Scholar
  • 169 www.bundesanzeiger.de/pub/de/amtlicher-teil?0&year=2017&edition=BAnz+AT+16.10.2017
  • 170 Yap JYY. et al. Critical Review of Transcutaneous Vagus Nerve Stimulation: Challenges for Translation to Clinical Practice. Front Neurosci 2020; 14: 284
    CrossrefPubMedGoogle Scholar
  • 171 www.gammacore.com/wp-content/uploads/2021/02/gammaCore-Sapphire-IFU.pdf
  • 172 Goadsby PJ, Grosberg BM, Mauskop A, Cady R, Simmons KA. Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia 2014; 34: 986-993
    CrossrefPubMedGoogle Scholar
  • 173 Nesbitt AD, Marin JCA, Tompkins E, Ruttledge MH, Goadsby PJ. Initial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment. Neurology 2015; 84: 1249-1253
    CrossrefPubMedGoogle Scholar
  • 174 https://edoc.ub.uni-muenchen.de/24617/1/Reidler_Paul.pdf
  • 175 Farmer AD, Strzelczyk A, Finiguerra A. et al. International Consensus Based Review and Recom-mendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020). Front. Hum. Neurosci. 2021; 14: 1-47 DOI: 10.3389/fnhum.2020.568051.
    CrossrefPubMedGoogle Scholar
  • 176 Kampusch S, Kaniusas E, Széles JC. 2013. “New approaches in multi-punctual percutaneous stimulation of the auricular vagus nerve,” in 2013 6th International IEEE/EMBS Conference on Neural Engineering (NER). San Diego, CA: 263-266 DOI: 10.1109/NER.2013.6695922
    CrossrefGoogle Scholar
  • 177 Englot DJ, Rolston JD. et al. Rates and Predictors of Seizure Freedom With Vagus Nerve Stimulation for Intractable Epilepsy. Neurosurgery 2016; 79: 345-353
    CrossrefPubMedGoogle Scholar
  • 178 Renfroe J, Wheless JW. Earlier use of adjunctive vagus nerve stimulation Therapy for refractory epilepsy. Neurology 2002; 59: 26-30
    CrossrefPubMedGoogle Scholar
  • 179 Brazdil M, Dolezalova I. et al. EEG Reactivity Predicts Individual Efficacy of Vagal Nerve Stimulation in Intractable Epileptics. Frontiers in Neurology 2019; 10: 392 DOI: 10.3389/fneur.2019.00392.
    CrossrefPubMedGoogle Scholar
  • 180 Babajani-Feremia A, Noorizadeh N. et al. Predicting seizure outcome of vagus nerve stimulation using MEG-based network topology. NeuroImage 2018; 19: 990-999
    CrossrefPubMedGoogle Scholar
  • 181 Xiong J, Cao Y. et al. Can we predict response to vagus nerve stimulation in intractable epilepsy. Int J Neurosience 2020; 130: 1063-1070 DOI: 10.1080/00207454.2020.1713777.
    CrossrefPubMedGoogle Scholar
  • 182 Lagae L, Verstrepen A, Nada A. et al. Vagus nerve stimulation in children with drug-resistant epi-lepsy: age at implantation and shorter durationof epilepsy as predictors of better efficacy?. Epileptic Disorders 2015; 17: 308-314
    CrossrefPubMedGoogle Scholar
  • 183 Mithani K, Mikhail M, Morgan BR. et al. Connectomic Profiling Identifies Responders to Vagus Nerve Stimulation. Annals Neurol 2019; 743-753 DOI: 10.1002/ana.25574.
    CrossrefPubMedGoogle Scholar
  • 184 Ghaemi K, Elsharkawy AE, Schulz R, Hoppe M, Polster T, Pannek H, Ebner A. Vagus nerve stimulation: outcome and predictors of seizure freedom in long-term follow-up. Seizure 2010; 19: 264-268
    CrossrefPubMedGoogle Scholar
  • 185 Janszky J, Hoppe M, Behne F, Tuxhorn I, Pannek HW, Ebner A. Vagus nerve stimulation: predictors of seizure freedom. J Neurol Neurosurg Psychiatry 2005; 76: 384-389
    CrossrefPubMedGoogle Scholar
  • 186 Bodin C. et al. Responders to Vagus Nerve Stimulation (VNS) in refractory epilepsy have reduced interictal cortical synchronicity on scalp EEG. Epilepsy Res 2015; 113: 98-103
    CrossrefPubMedGoogle Scholar
  • 187 Schulze-Bonhage A, Hamer HM, Hirsch M. et al. Invasive Stimulationsverfahren und EEG-Diagnostik bei Epilepsien. Nervenarzt 2016; 87: 829-837
    CrossrefPubMedGoogle Scholar
  • 188 Möddel G, Coenen VA, Elger CE. Invasive Neurostimulation in der Epilepsietherapie. Der Nervenarzt 2012; 83: 1001-1005
    CrossrefPubMedGoogle Scholar
  • 189 The Vagus Nerve Stimulation Study Group A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group. Neurology 1995; 45: 224-230
    PubMedGoogle Scholar
  • 190 Handforth A, DeGiorgio CM, Schachter SC. et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998; 51: 48-55
    CrossrefPubMedGoogle Scholar
  • 191 Fisher RS, Handforth A. Reassessment: vagus nerve stimulation for epilepsy: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1999; 53: 666-669
    CrossrefPubMedGoogle Scholar
  • 192 Klinkenberg S, Aalbers MW. Vles et al. Vagus nerve stimulation in children with intractable epilepsy: a randomized controlled trial. Dev Med Child Neurol 2012; 54: 855-861
    CrossrefPubMedGoogle Scholar
  • 193 Morris GL, Mueller WM. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01–E05. Neurology 1999; 53: 1731-1735
    CrossrefPubMedGoogle Scholar
  • 194 Tatum WO, Johnson KD, Goff S. et al. Vagus nerve stimulation and drug reduction. Neurology 2001; 56: 561-563
    CrossrefPubMedGoogle Scholar
  • 195 McHugh JC, Singh HW, Phillips J. et al. Outcome measurement after vagal nerve stimulation therapy: proposal of a new classification. Epilepsia 2007; 48: 375-378
    CrossrefPubMedGoogle Scholar
  • 196 Orosz I, McCormick D, Zamponi N. et al. Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children. Epilepsia 2014; 55: 1576-1584
    CrossrefPubMedGoogle Scholar
  • 197 Englot DJ, Rolston JD, Wright CW. et al. Rates and predictors of seizure freedom with vagus nerve stimulation for intractable Epilepsy. Neurosurgery 2015; 79: 345-353
    CrossrefPubMedGoogle Scholar
  • 198 Montavont A, Demarquay G, Ryvlin P. et al. Efficacité de la stimulation intermittente du nerf vague dans les épilepsies pharmaco-résistantes non chirurgicales de l’adolescent et de l’adulte. Revue neurologique 2007; 163: 1169-1177
    CrossrefPubMedGoogle Scholar
  • 199 Alexopoulos AV, Kotagal P, Loddenkemper T. et al. Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy. Seizure 2006; 15: 491-503
    CrossrefPubMedGoogle Scholar
  • 200 Ardesch JJ, Buschman HPJ, Wagener-Schimmel LJJC, van der Aa HE, Hageman G. Vagus nerve stimulation for medically refractory epilepsy. A long-term follow-up study. Seizure 2007; 16: 579-585
    CrossrefPubMedGoogle Scholar
  • 201 Hamilton P. et al. Clinical outcomes of VNS therapy with AspireSR (including cardiac-based seizure detection) at a large complex epilepsy and surgery centre. Seizure 2018; 58: 120-126 DOI: 10.1016/j.seizure.2018.03.022.
    CrossrefPubMedGoogle Scholar
  • 202 Data P, Galla K, Sajja K, Wichman C, Wang H, Madhavan D. Vagus nerve stimulation with tachycardia detection provides additional seizure reduction compared to traditional vagus nerve stimulation. Epilepsy & Behavior 2020; 111: 107280 DOI: 10.1016/j.yebeh.2020.107280.
    CrossrefPubMedGoogle Scholar
  • 203 Dibue M, Greco T, Spoor JKH, Tahir Z, Specchio N, Hänggi D, Steiger H, Kamp M. Vagus nerve stimulation in patients with Lennox-Gastaut syndrome: A meta-analysis. Acta Neurol Scand 2020; 143: 497-508 DOI: 10.1111/ane.13375.
    CrossrefPubMedGoogle Scholar
  • 204 Annegers JF, Coan SP, Hauser WA, Leestma J, Duffell W, Tarver B. Epilepsy, vagal nerve stimulation by the NCP system, mortality, and sudden, unexpected, unexplained death. Epilepsia 1998; 39: 206-212
    CrossrefPubMedGoogle Scholar
  • 205 Tatum WO, Vale FL. Vagus nerve stimulation and cardiac asystole. Epilepsia 2009; 50: 2671-2672
    CrossrefPubMedGoogle Scholar
  • 206 Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Time trends in incidence, mortality, and case-fatality after first episode of status epilepticus. Epilepsia 2001; 42: 1031-1035
    CrossrefPubMedGoogle Scholar
  • 207 Stelzer FG, Bustamante G, Sander H. et al. Short-term mortality and prognostic factors related to status epilepticus. DOI: 10.1590/0004-282X20150082.
    CrossrefPubMedGoogle Scholar
  • 208 Helmers SL, Duh MS, Guerin A. et al. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy. Eur J Paedriatr Neurol 2012; 16: 449-458
    CrossrefPubMedGoogle Scholar
  • 209 Dibue-Adjei M, Brigo F, Yamamoto T, Vonck K, Trinka E. Vagus nerve stimulation in refractory and super-refractory status epilepticus e A systematic review. 2019. Brain Stimulation. 2019. 12. 1101-1110 Elsevier Inc; DOI: 10.1016/j.brs.2019.05.011
    CrossrefGoogle Scholar
  • 210 Ryvlin P, Gilliam FG, Nguyen DK. et al. The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial. Epilepsia 2014; 55: 893-900
    CrossrefPubMedGoogle Scholar
  • 211 Schulze-Bonhage A, Hamer HM, Hirsch M. et al. Invasive Stimulationsverfahren und EEG-Diagnostik bei Epilepsien. Nervenarzt 2016; 87: 829-837 DOI: 10.1007/s00115-016-0159-0.
    CrossrefPubMedGoogle Scholar
  • 212 Baumgartner C. Eine kritische BilanzNeurostimulation in epilepsy treatmentA critical review Nervenheilkunde. 2007. Schattauer GmbH; 26. 999-1005 DOI: 10.1055/s-0038-1626953
    Article in Thieme ConnectGoogle Scholar
  • 213 Ben-Menachem E. Vagus nerve stimulation, side effects, and long-term safety. J Clin Neurophysiol 2001; 18: 415-418
    CrossrefPubMedGoogle Scholar
  • 214 Ekmekci H, Kaptan H. Vagus Nerve Stimulation. Open access Macedonian journal of medical sciences 2017; 5: 391-394
    CrossrefPubMedGoogle Scholar
  • 215 Panebianco M, Zavanone C, Dupont S, Restivo DA, Pavone A. Vagus nerve stimulation therapy in partial epilepsy. A review. Acta neurologica Belgica 2016; 116: 241-248
    CrossrefPubMedGoogle Scholar
  • 216 Amar AP. Vagus nerve stimulation for the treatment of intractable epilepsy. Expert review of neurotherapeutics 2007; 7: 1763-1773
    CrossrefPubMedGoogle Scholar
  • 217 Chavel SM, Westerveld M, Spencer S. Long-term outcome of vagus nerve stimulation for refractory partial epilepsy. Epilepsy & behavior : E&B 2003; 4: 302-309
    CrossrefPubMedGoogle Scholar
  • 218 Morris GL, Mueller WM. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. Neurology 1999; 53: 1731
    CrossrefPubMedGoogle Scholar
  • 219 Hermann BP, Trenerry MR, Colligan RC. Learned helplessness, attributional style, and depression in epilepsy. Bozeman Epilepsy Surgery Consortium. Epilepsia 1996; 37: 680-686
    CrossrefPubMedGoogle Scholar
  • 220 Huf RL, Mamelak A, Kneedy-Cayem K. Vagus nerve stimulation therapy. 2-year prospective open-label study of 40 subjects with refractory epilepsy and low IQ who are living in long-term care facilities. Epilepsy & behavior : E&B 2005; 6: 417-423
    CrossrefPubMedGoogle Scholar
  • 221 Wasade VS, Schultz L, Mohanarangan K, Gaddam A, Schwalb JM, Spanaki-Varelas M. Long-term seizure and psychosocial outcomes of vagus nerve stimulation for intractable epilepsy. Epilepsy & behavior : E&B 2015; 53: 31-36
    CrossrefPubMedGoogle Scholar
  • 222 Carius A, Wintermantel A. Vagusnervstimulationstherapie bei Epilepsiepatienten. Langzeitoutcome und Nebenwirkungen: eine retrospektive Analyse. In: Der Nervenarzt 2013; 84: 1473-1485
    CrossrefPubMedGoogle Scholar
  • 223 Scherrmann J, Hoppe C, Kral T, Schramm J, Elger CE. Vagus nerve stimulation. Clinical experience in a large patient series. Journal of clinical neurophysiology: official publication of the American Electroencephalographic Society 2001; 18: 408-414
    CrossrefPubMedGoogle Scholar
  • 224 Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy research 2000; 42: 203-210
    CrossrefPubMedGoogle Scholar
  • 225 Klinkenberg S, Majoie HJM, van der Heijden MM, Rijkers K, Leenen L, Aldenkamp AP. Vagus nerve stimulation has a positive effect on mood in patients with refractory epilepsy. Clinical neurology and neurosurgery 2012; 114: 336-340
    CrossrefPubMedGoogle Scholar
  • 226 Scherrmann J, Hoppe C, Kral T, Schramm J, Elger CE. Vagus nerve stimulation. Clinical experience in a large patient series. Journal of clinical neurophysiology: official publication of the American Electroencephalographic Society 2001; 18: 408-414
    CrossrefPubMedGoogle Scholar
  • 227 Dodrill CB, Morris GL. Effects of Vagal Nerve Stimulation on Cognition and Quality of Life in Epilepsy. Epilepsy & behavior : E&B 2001; 2: 46-53
    CrossrefPubMedGoogle Scholar
  • 228 Bernstein AL, Hess T. Vagus nerve stimulation therapy for pharmacoresistant epilepsy. Effect on health care utilization. Epilepsy & behavior : E&B 2007; 10: 134-137
    PubMedGoogle Scholar
  • 229 Alexopoulos AV, Kotagal P, Loddenkemper T, Hammel J, Bingaman WE. Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy. Seizure 2006; 15: 491-503
    CrossrefPubMedGoogle Scholar
  • 230 McLachlan RS, Sadler M, Pillay N, Guberman A, Jones M. et al. Quality of life after vagus nerve stimulation for intractable epilepsy. Is seizure control the only contributing factor? European neurology 2003; 50: 16-19
    PubMedGoogle Scholar
  • 231 Chavel SM, Westerveld M, Spencer S. Long-term outcome of vagus nerve stimulation for refractory partial epilepsy. In: Epilepsy & behavior: E&B 2003; 4: 302-309
    CrossrefPubMedGoogle Scholar
  • 232 Olin B, Javewardene A, Bunker M, Moreno F. Mortality and Suicide Risk in Treatment-Resistant Depression: An Observational Study of the Long-Term Impact of Intervention. plos one 2012; 7: 48002 DOI: 10.1371/journal.pone.0048002.
    CrossrefPubMedGoogle Scholar
  • 233 Schulze-Bonhage A, Hamer HM, Hirsch M. et al. Invasive Stimulationsverfahren und EEG-Diagnostik bei Epilepsien. Nervenarzt 2016; 87: 829-837 DOI: 10.1007/s00115-016-0159-0.
    CrossrefPubMedGoogle Scholar
  • 234 Stefan H, Kreiselmeyer G, Kerling F. et al. Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial. Epilepsia 2012; 53: 115-118
    CrossrefPubMedGoogle Scholar
  • 235 Bauer S, Baier H, Baumgartner C. et al. Transcutaneous Vagus Nerve Stimulation (tVNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial (cMPsE02). Brain Stimulation 2016; 9: 356-363
    CrossrefPubMedGoogle Scholar
  • 236 Hermann S, Kreiselmeyer G, Kerling F, Kurzbuch K, Rauch C, Heers M. et al. Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies. A proof of concept trial. In: Epilepsia 2012; 53: 115-118
    CrossrefPubMedGoogle Scholar
  • 237 Aihua L, Lu S, Liping L, Xiuru W, Hua L, Yuping W. (): A controlled trial of transcutaneous vagus nerve stimulation for the treatment of pharmacoresistant epilepsy. Epilepsy & behavior: E&B 2014; 39: 105-110
    CrossrefPubMedGoogle Scholar
  • 238 Jacobs HIL, Riphagen JM, Razat CM. et al. Transcutaneous vagus nerve stimulation boosts asso-ciative memory in older individuals. Neurobiol Aging 2015; 36: 1860-1867
    CrossrefPubMedGoogle Scholar
  • 239 Morris GL. A retrospective analysis of the effects of magnet-activated stimulation in conjunction with vagus nerve stimulation therapy. Epilepsy&behavior 2003; 4: 740-745
    PubMedGoogle Scholar
  • 240 Hermann S, Kreiselmeyer G, Kerling F, Kurzbuch K, Rauch C, Heers M. et al. Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies. A proof of concept trial. In: Epilepsia 2012; 53: 115-118
    CrossrefPubMedGoogle Scholar
  • 241 Aihua L, Lu S, Liping L, Xiuru W, Hua L, Yuping W. A controlled trial of transcutaneous vagus nerve stimulation for the treatment of pharmacoresistant epilepsy. Epilepsy & behavior : E&B 2014; 39: 105-110
    CrossrefPubMedGoogle Scholar
  • 242 Bauer S, Baier H, Baumgartner C, Bohlmann K, Fauser S, Graf W. et al. Transcutaneous Vagus Nerve Stimulation (tVNS) for Treatment of Drug-Resistant Epilepsy. A Randomized, Double-Blind Clinical Trial (cMPsE02). Brain stimulation 2016; 9: 356-363
    CrossrefPubMedGoogle Scholar
  • 243 Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 2000; 42: 203-210
    CrossrefPubMedGoogle Scholar
  • 244 Panebianco M, Zavanone C, Dupont S, Restivo DA, Pavone A. Vagus nerve stimulation therapy in partial epilepsy. A review. Acta neurologica Belgica 2016; 116: 241-248
    CrossrefPubMedGoogle Scholar
  • 245 Rush AJ, Marangell LB, Sackeim HA. et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005; 58: 347-354
    CrossrefPubMedGoogle Scholar
  • 246 Sackeim HA. et al. Vagus Nerve Stimulation (VNS™) for Treatment-Resistant Depression: Efficacy, Side Effects, and Predictors of Outcome. Neuropsychopharmacology 2001; 25: 713-728
    CrossrefPubMedGoogle Scholar
  • 247 Barth J, Schuhmacher M. et al. Depression as a risk factor for mortality in patients with coronary heart desease. Psychosomatic med 2004; 66: 802-813
    CrossrefPubMedGoogle Scholar
  • 248 Ladwig KH. et al. Depression: Ein nach wie vor unterschätztes Risiko für die Entwicklung und Progressionder koronaren Herzerkrankung. Bundesgesundheitsblatt 2011; 54: 59-65
    CrossrefPubMedGoogle Scholar
  • 249 Rosengren A, Hawken S, Ounpuu S, Sliwa K. et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTER-HEART study): case-control study. The INTERHEART study. Lancet 2004; 364: 953-962
    CrossrefPubMedGoogle Scholar
  • 250 Mende A. Das Herz leidet mit Pharmazeutische Zeitung. 2011: 39 https://www.gbe-bund.de/gbe/abrechnung.prc_abr_test_logon?p_uid=gast&p_aid=0&p_knoten=FID&p_sprache=E&p_suchstring=701411
    Google Scholar
  • 251 Olin B, Javewardene A, Bunker M, Moreno F. (): Mortality and Suicide Risk in Treatment-Resistant Depression: An Observational Study of the Long-Term Impact of Intervention. PLOS ONE 2012; 7: e48002 DOI: 10.1371/journal.pone.0048002.
    CrossrefPubMedGoogle Scholar
  • 252 Hein E, Nowak M, Kiess O. et al. Auricular transcutaneous electrical nerve stimulation in depressed patients: a randomized controlled pilot study. J Neural Transmission (Vienna) 2013; 120: 821-827
    CrossrefPubMedGoogle Scholar
  • 253 Kraus T, Hösl K, Kiess O. et al. BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation. J Neural Transmission (Vienna) 2007; 114: 1485-1493
    CrossrefPubMedGoogle Scholar
  • 254 Rong P, Liu J, Wang L. et al. Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder: A nonrandomized controlled pilot study. J Affect Disord 2016; 195: 172-179
    CrossrefPubMedGoogle Scholar
  • 255 Trevizol AP, Shiozawa P, Taiar I. et al. Transcutaneous vagus nerve stimulation (taVNS) for major depressive disorder: an open label proof-of-concept trial. Brain Stimul 2016; 9: 453-454
    CrossrefPubMedGoogle Scholar
  • 256 Jacobs HIL, Riphagen JM, Razat CM. et al. Transcutaneous vagus nerve stimulation boosts associative memory in older individuals. Neurobiol Aging 2015; 36: 1860-1867
    CrossrefPubMedGoogle Scholar
  • 257 Strzelczyk A, Griebel C, Lux W. et al. The Burden of Severely Drug-Refractory Epilepsy: A Comparative Longitudinal Evaluation of Mortality, Morbidity, Resource Use, and Cost Using German Health Insurance Data. Front Neurol 2017; 8: 712 DOI: 10.3389/fneur.2017.00712.
    CrossrefPubMedGoogle Scholar
  • 258 Yuan H, Silberstein SD. Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part I. Headache 2016; 56: 71-78
    CrossrefPubMedGoogle Scholar
  • 259 errier RL, Ikeda T. Ambulatory ECG-based T-wave alternans monitoring for risk assessment and guiding medical therapy: mechanisms and clinical applications. Prog Cardiovasc Dis 2013; 56: 172-185
    CrossrefPubMedGoogle Scholar
  • 260 Zanobetti A, Stone PH, Speizer FE. et al. T-wave alternans, air pollution and traffic in high-risk subjects. Am J Cardiol 2009; 104: 665-670
    CrossrefPubMedGoogle Scholar
  • 261 Verrier RL, Nearing BD. et al. Baseline elevation and reduction in cardiac electrical instability assessed by quantitative T-wave alternans in patients with drug-resistant epilepsy treated with vagus nerve stimulation in the AspireSR E-36 trial. Epilepsy & Behavior 2016; 62: 85-89
    CrossrefPubMedGoogle Scholar
  • 262 Strzelczyck A, Adjei P, Scott CA. et al. Postictal increase in T-wave alternans after generalized tonic-clonic seizures. Epilepsia 2011; 52: 2112-2117
    CrossrefPubMedGoogle Scholar
  • 263 Libbus I, Nearing BD, Amurthur B. et al. Autonomic regulation therapy suppresses quantitative T-wave alternans and improves baroreflex sensitivity in patients with heart failure enrolled in the AN-THEM-HF study. Heart Rhythm 2016; 13: 721-728
    CrossrefPubMedGoogle Scholar
  • 264 Premchand RK, Sharma K, Mittal S, Monteiro R, Dixit S, Libbus I. et al. Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure. Results of the ANTHEM-HF trial. Journal of cardiac failure 2014; 20: 808-816
    CrossrefPubMedGoogle Scholar
  • 265 https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00009292
  • 266 Benrath J, Hatzenbühler M, Fresenius M, Heck M. Kopf- und Gesichtsschmerz. Repetitorium Schmerztherapie. Springer; Berlin, Heidelberg: 2020. 1. 191-225 DOI: 10.1007/978-3-662-61783-0_9
    CrossrefGoogle Scholar
  • 267 Diener HC, Gaul C, Kropp P. et al. (2018) Therapie der Migräneattacke und Prophylaxe der Migräne, S1-Leitlinie. In: Deutsche Gesellschaft für Neurologie (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie. https://dgn.org/leitlinien/3583-ll-030-057-2018-therapie-der-migraeneattacke-und-prophylaxe-der-migraene. Zugegriffen: 22. Juni 2020
  • 268 Kirchner A, Birklein F, Stefan H, Handwerker HO. Left vagus nerve stimulation suppresses experimentally induced pain. Neurology 2000; 55: 1167-1171
    CrossrefPubMedGoogle Scholar
  • 269 Busch V, Zeman F, Heckel A, Menne F, Ellrich J, Eichhammer P. The effect of transcutaneous vagus nerve stimulation on pain perception – an experimental study. Brain Stimul 2013; 6: 202-209
    CrossrefPubMedGoogle Scholar
  • 270 Howland RobertH.. New developments with vagus nerve stimulation therapy. Journal of psychosocial nursing and mental health services 2014; 52: S. 11-14
    CrossrefPubMedGoogle Scholar
  • 271 Hord E, Evans M, Mueed S. The effect of vagus nerve stimulation on migraines. J Pain 2003; 4: 530-534
    CrossrefPubMedGoogle Scholar
  • 272 Lenaerts M, Oommen K, Couch J. Can vagus nerve stimulation help mi-graine?. Cephalalgia 2008; 28: 392-395
    CrossrefPubMedGoogle Scholar
  • 273 Magis D, Gerard P, Schoenen J. Transcutaneous Vagus Nerve Stimulation (tVNS) for headache prophylaxis: initial experience. J Headache Pain 2013; 14: 198
    CrossrefPubMedGoogle Scholar
  • 274 Gaul C, Diener HC, Silver N, Magis D, Reuter U, Andersson A. et al. Non-invasive vagus nerve stimulation for PREVention and Acute treatment of chronic cluster headache (PREVA): A randomised controlled study. Cephalalgia 2016; 36: 534-546
    CrossrefPubMedGoogle Scholar
  • 275 Goadsby PJ, Grosberg BM, Mauskop A, Cady R, Simmons KA. Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia 2014; 34: 986-993
    CrossrefPubMedGoogle Scholar
  • 276 Straube A, Ellrich J, Eren O, Blum B, Ruscheweyh R. Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t- VNS): a randomized, monocentric clinical trial. J Headache Pain 2015; 16: 543
    CrossrefPubMedGoogle Scholar
  • 277 Diener H, Brössner G, Frank F, Holle D, Nägel S, Reuter U. Neues bei Migräne – Update 2021 Neurologie up2date 2021; 4: 195-214 DOI: 10.1055/a-1163-6539.
    PubMed
  • 278 Diener HC, Goadsby PJ, Ashina M. et al. Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial. Cephalalgia 2019; 39: 1475-1487
    CrossrefPubMedGoogle Scholar
  • 279 Martelletti P, Jensen RH, Antal A. et al. Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain 2013; 14: 86
    CrossrefPubMedGoogle Scholar
  • 280 Goadsby PJ, Grosberg BM, Mauskop A, Cady R, Simmons KA. Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia. 2014; 34: 986-993
    CrossrefPubMedGoogle Scholar
  • 281 Deutsches Register Klinischer Studien: Transkutane Vagusnervstimulation zur Therapie der chronischen Migräne https://drks-neu.uniklinik- frei-burg.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00003681 2012
  • 282 Chun Chieh Y, Wang HH, Chun Cho Y. et al. High risk of gastrointestinal hemorrhage in patients with Epilepsy: A nationwide cohort study. Mayo Clin Proceedings 2013; 88: 1091-1098 DOI: 10.1016/j.mayocp.2013.06.024.
    CrossrefPubMedGoogle Scholar
  • 283 Camara-Lemarroy C, Escobedo-Zuniga N, Ortiz-Zacarias D. et al. Prevalence and impact of irritable bowel syndrome in people with epilepsy. Epilepsy & Behavior 2016; 63: 29-33
    CrossrefPubMedGoogle Scholar
  • 284 Bonaz B, Sinniger V. et al. Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. J Physiol 2016; 594: 5781-5790 DOI: 10.1113/JP271539.
    CrossrefPubMedGoogle Scholar
  • 285 Yuan H, Silberstein S. Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part II. Headache 2016; 56: 259-266 DOI: 10.1111/head.12650. Epub 2015 Sep 18
    CrossrefPubMedGoogle Scholar
  • 286 Bonaz B, Picq C, Sinniger V, Mayolá JF, Clarencon D. Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol Motil 2013; 25: 208-221
    CrossrefPubMedGoogle Scholar
  • 287 Elger G, Hoppe C, Falkai P. et al. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 2000; 42: 203-210
    CrossrefPubMedGoogle Scholar
  • 288 Sackeim HA, Keilp JG, Rush AJ. et al. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14: 53-62
    PubMedGoogle Scholar
  • 289 Beekwilder JP, Beems T. Overview of the clinical applications of vagus nerve stimulation. J Clin Neurophysiol 2010; 27: 130-138
    CrossrefPubMedGoogle Scholar
  • 290 Sjögren MJC, Hellström PTO, Jonsson MAG. et al. Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer’s disease: a pilot study. J Clin Psychiatry 2002; 63: 972-980
    CrossrefPubMedGoogle Scholar
  • 291 Vonck K, Raedt R, Naulaerts J. et al. Vagus nerve stimulation…25 years later! What do we know about the effects on cognition?. Neurosci Biobehav Rev 2014; 45: 63-71
    CrossrefPubMedGoogle Scholar
  • 292 Strzelczyk A, Willems LM. Gesundheitsökonomie. In: Schmitt F, Stefan H, Holtkamp M eds. Epileptische Anfälle und Epilepsien im Erwachsenenalter. Springer; Berlin, Heidelberg: 2020. DOI: 10.1007/978-3-662-59198-7_5
    CrossrefGoogle Scholar
  • 293 Strzelczyk A. et al. Cost of epilepsy: a systematic review. PharmacoEconomics 2008; 26: 463-476
    CrossrefPubMedGoogle Scholar
  • 294 Strzelczyk A. et al. Evaluation of health-care utilization among adult patients with epilepsy in Ger-many. Epilepsy Behav 2012; 23: 451-457
    CrossrefPubMedGoogle Scholar
  • 295 Helmers SL. et al. Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy. Epilepsy Behav 2011; 22: 370-375
    CrossrefPubMedGoogle Scholar
  • 296 Forbes R. Cost-utility of vagus nerve stimulation (VNS) therapy for medically refractory epilepsy – an update. Seizure 2008; 17: 387-388
    CrossrefPubMedGoogle Scholar
  • 297 Benbadis SR. et al. MRI of the brain is safe in patients implanted with the vagus nerve stimulator. Seizure 2001; 10: 512-515
    CrossrefPubMedGoogle Scholar
  • 298 Fetzer S. et al. A systematic review of magnetic resonance imaging in patients with an implanted vagus nerve stimulation system. Neuroradiology 2021; 63: 1407-1417
    CrossrefPubMedGoogle Scholar
  • 299 Ding J, Wang L, Wang C, Gao C, Sun T. Is vagal-nerve stimulation safe during pregnancy? A mini review. Epilepsy Research 2021; 174: 106671
    CrossrefPubMedGoogle Scholar
  • 300 https://vnstherapy.de/safety-information